Literature DB >> 12386336

Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.

Jiyan Ma1, Susan Lindquist.   

Abstract

A rare conformation of the prion protein, PrPSc, is found only in mammals with transmissible prion diseases and represents either the infectious agent itself or a major component of it. The mechanism for initiating PrPSc formation is unknown. We report that PrP retrogradely transported out of the endoplasmic reticulum produced both amorphous aggregates and a PrPSc-like conformation in the cytosol. The distribution between these forms correlated with the rate of appearance in the cytosol. Once conversion to the PrPSc-like conformation occurred, it was sustained. Thus, PrP has an inherent capacity to promote its own conformational conversion in mammalian cells. These observations might explain the origin of PrPSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386336     DOI: 10.1126/science.1073619

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  69 in total

Review 1.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment.

Authors:  Carlos J Bosques; Barbara Imperiali
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205

3.  Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.

Authors:  Erwann Rousseau; Benjamin Dehay; Léa Ben-Haïem; Yvon Trottier; Michel Morange; Anne Bertolotti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

4.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

5.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

6.  Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway.

Authors:  Sang-Wook Kang; Neena S Rane; Soo Jung Kim; Jennifer L Garrison; Jack Taunton; Ramanujan S Hegde
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

7.  Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.

Authors:  Tao Pan; Poki Wong; Binggong Chang; Chaoyang Li; Ruliang Li; Shin-Chung Kang; Thomas Wisniewski; Man-Sun Sy
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Alternative translation initiation generates cytoplasmic sheep prion protein.

Authors:  Christoffer Lund; Christel M Olsen; Susan Skogtvedt; Heidi Tveit; Kristian Prydz; Michael A Tranulis
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

9.  Chemical induction of misfolded prion protein conformers in cell culture.

Authors:  Sina Ghaemmaghami; Julie Ullman; Misol Ahn; Susan St Martin; Stanley B Prusiner
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

10.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.